Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
The Lancet. Haematology
|
February 7, 2017
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
Esther N Oliva, Caterina Alati, Valeria Santini, et al.
European Journal of Haematology
|
July 20, 2024
Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey
Bruno Fattizzo, Valentina Carrai, Monica Crugnola, et al.
Leukemia Research
|
June 3, 2026
Association of hypomethylating agents + venetoclax in the real-life treatment of Myeloproliferative Neoplasms in blastic phase
Roberto Latagliata, Novella Pugliese, Dorela Lame, et al.
British Journal of Haematology
|
August 26, 2025
Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study
Elisa Lucchini, Nicola Vianelli, Ugo Consoli, et al.
American Journal of Hematology
|
July 5, 2017
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems
Rena Buckstein, Enrico Balleari, Richard Wells, et al.
Nature Communications
|
June 20, 2020
Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis
Karla J Suchacki, Adriana A S Tavares, Domenico Mattiucci, et al.
Cancers
|
May 14, 2025
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers
Elena Crisà, Daniela Cilloni, Marta Riva, et al.
American Journal of Hematology
|
December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort
Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2023
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
Esther Natalie Oliva, Marta Riva, Pasquale Niscola, et al.
Leukemia
|
August 5, 2024
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study
Elena Crisà, Elvira Mora, Ulrich Germing, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
The Lancet. Haematology
|
February 7, 2017
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
Esther N Oliva, Caterina Alati, Valeria Santini, et al.
European Journal of Haematology
|
July 20, 2024
Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey
Bruno Fattizzo, Valentina Carrai, Monica Crugnola, et al.
Leukemia Research
|
June 3, 2026
Association of hypomethylating agents + venetoclax in the real-life treatment of Myeloproliferative Neoplasms in blastic phase
Roberto Latagliata, Novella Pugliese, Dorela Lame, et al.
British Journal of Haematology
|
August 26, 2025
Real-world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study
Elisa Lucchini, Nicola Vianelli, Ugo Consoli, et al.
American Journal of Hematology
|
July 5, 2017
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems
Rena Buckstein, Enrico Balleari, Richard Wells, et al.
Nature Communications
|
June 20, 2020
Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis
Karla J Suchacki, Adriana A S Tavares, Domenico Mattiucci, et al.
Cancers
|
May 14, 2025
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers
Elena Crisà, Daniela Cilloni, Marta Riva, et al.
American Journal of Hematology
|
December 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort
Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2023
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
Esther Natalie Oliva, Marta Riva, Pasquale Niscola, et al.
Leukemia
|
August 5, 2024
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study
Elena Crisà, Elvira Mora, Ulrich Germing, et al.
Page
of 9